Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers80

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers38

Views

Views
May 20252
June 20252
July 202518
August 20250
September 20252
October 20255
November 20259
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil17
United States11
United Kingdom3
Mexico2
Argentina1
Ecuador1
Spain1
Peru1
Paraguay1
 

Top cities views

Views
Rio de Janeiro3
Contagem2
Amite1
Ashburn1
Asunción1
Cambridge1
Capâo Bonito1
Chihuahua City1
Chimbote1
Curitiba1